Structure-activity relationship study of novel NR2B-selective antagonists with arylamides to avoid reactive metabolites

被引：11
|
作者：
Kawai, Makoto
Sakurada, Isao
Morita, Asato
Iwamuro, Yuko
Ando, Kazuo
Omura, Hirofumi
Sakakibara, Sachiko
Masuda, Tsutomu
Koike, Hiroki
Honma, Teruki
Hattori, Kazunari
Takashima, Tadayuki
Mizuno, Kunihiko
Mizutani, Mayumi
Kawamura, Mitsuhiro
机构：
[1] Pfizer Global Res & Dev, Nagoya Labs, Discovery Chem, Aichi 4702393, Japan
[2] Pfizer Global Res & Dev, Nagoya Labs, Pharmacokinet Dynam & Metab, Aichi 4702393, Japan
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 20期
关键词：
reactive metabolite; bioactivation; NR2B; NMDA; metabolic stability;
D O I：
10.1016/j.bmcl.2007.08.033
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A novel potent NMDA-NR2B selective antagonist (5b) without the reactive metabolites formation issue was identified. Through this study, a close correlation between reactive metabolites formation and calculated HOMO energies of parent compounds was found. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码：5537 / 5542
页数：6
相关论文
共 50 条
  • [1] A novel series of benzimidazole NR2B-selective NMDA receptor antagonists
    Davies, David J.
    Crowe, Matthew
    Lucas, Nolwenn
    Quinn, Joanna
    Miller, David D.
    Pritchard, Sara
    Grose, David
    Bettini, Ezio
    Calcinaghi, Novella
    Virginio, Caterina
    Abberley, Lee
    Goldsmith, Paul
    Michel, Anton D.
    Chessell, Iain P.
    Kew, James N. C.
    Miller, Neil D.
    Gunthorpe, Martin J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (07) : 2620 - 2623
  • [2] Orally efficacious NR2B-selective NMDA receptor antagonists
    Claiborne, CF
    McCauley, JA
    Libby, BE
    Curtis, NR
    Diggle, HJ
    Kulagowski, JJ
    Michelson, SR
    Anderson, KD
    Claremon, DA
    Freidinger, RM
    Bednar, RA
    Mosser, SD
    Gaul, SL
    Connolly, TM
    Condra, CL
    Bednar, B
    Stump, GL
    Lynch, JJ
    Macaulay, A
    Wafford, KA
    Koblan, KS
    Liverton, NJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (04) : 697 - 700
  • [3] Structure-activity relationship of N-(phenylalkyl)cinnamides as novel NR2B subtype-selective NMDA receptor antagonists
    Tamiz, AP
    Cai, SX
    Zhou, ZL
    Yuen, PW
    Schelkun, RM
    Whittemore, ER
    Weber, E
    Woodward, RM
    Keana, JFW
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (17) : 3412 - 3420
  • [4] Quantitative structure-activity relationship study of novel α1a-selective adrenoceptor antagonists
    Singh, P
    Kumar, R
    JOURNAL OF ENZYME INHIBITION, 2001, 16 (04): : 331 - 338
  • [5] Insights into Structure-Activity Relationships and CNS Therapeutic Applications of NR2B Selective Antagonists
    Beinat, C.
    Banister, S.
    Moussa, I.
    Reynolds, A. J.
    McErlean, C. S. P.
    Kassiou, M.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (34) : 4166 - 4190
  • [6] Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonists
    Nguyen, Kevin T.
    Claiborne, Christopher F.
    McCauley, John A.
    Libby, Brian E.
    Claremon, David A.
    Bednar, Rodney A.
    Mosser, Scott D.
    Gaul, Stanley L.
    Connolly, Thomas M.
    Condra, Cindra L.
    Bednar, Bohumil
    Stump, Gary L.
    Lynch, Joseph J.
    Koblan, Kenneth S.
    Liverton, Nigel J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (14) : 3997 - 4000
  • [7] Discovery of NR2B-selective antagonists via scaffold hopping and pharmacokinetic profile optimization
    Anan, Kosuke
    Masui, Moriyasu
    Tazawa, Aya
    Tomida, Minoru
    Haga, Yoshihiro
    Kume, Masaharu
    Yamamoto, Shoichi
    Shinohara, Shunji
    Tsuj, Hiroki
    Shimada, Shinji
    Yagi, Shigenori
    Hasebe, Nobuyoshi
    Kai, Hiroyuki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (09) : 1143 - 1147
  • [8] Anti-parkinsonian effect of NR2B-selective NMDA antagonists: A striatal mechanism of action?
    Nash, JE
    Crossman, AR
    Brotchie, JM
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 : U53 - U53
  • [9] QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP STUDY OF 8-STYRYLXANTHINES AS A2-SELECTIVE ADENOSINE ANTAGONISTS
    OJHA, TN
    TIWARI, S
    SHARMA, RC
    SINGH, P
    INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 1995, 34 (05): : 452 - 455
  • [10] Design, synthesis, and structure-activity relationship of novel CCR2 antagonists
    Kothandaraman, Shankaran
    Donnely, Karla L.
    Butora, Gabor
    Jiao, Richard
    Pasternak, Alexander
    Morriello, Gregori J.
    Goble, Stephen D.
    Zhou, Changyou
    Mills, Sander G.
    MacCoss, Malcolm
    Vicario, Pasquale P.
    Ayala, Julia M.
    DeMartino, Julie A.
    Struthers, Mary
    Cascieri, Margaret A.
    Yang, Lihu
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (06) : 1830 - 1834
12345